RhumbLine Advisers’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,092
| Closed | -$1.42K | – | 4224 |
|
|
2024
Q2 | $1.42K | Hold |
1,092
| – | – | ﹤0.01% | 4212 |
|
|
2024
Q1 | $1.67K | Hold |
1,092
| – | – | ﹤0.01% | 4102 |
|
|
2023
Q4 | $1.28K | Hold |
1,092
| – | – | ﹤0.01% | 4134 |
|
|
2023
Q3 | $950 | Hold |
1,092
| – | – | ﹤0.01% | 4185 |
|
|
2023
Q2 | $1.22K | Buy |
+1,092
| New | +$1.22K | ﹤0.01% | 4270 |
|
|
2019
Q2 | – | Sell |
-36,309
| Closed | -$50K | – | 2973 |
|
|
2019
Q1 | $50K | Sell |
36,309
-670
| -2% | -$923 | ﹤0.01% | 2919 |
|
|
2018
Q4 | $40K | Buy |
36,979
+12,076
| +48% | +$13.1K | ﹤0.01% | 2955 |
|
|
2018
Q3 | $153K | Sell |
24,903
-1,800
| -7% | -$11.1K | ﹤0.01% | 2799 |
|
|
2018
Q2 | $285K | Buy |
26,703
+8,057
| +43% | +$86K | ﹤0.01% | 2558 |
|
|
2018
Q1 | $200K | Buy |
18,646
+990
| +6% | +$10.6K | ﹤0.01% | 2604 |
|
|
2017
Q4 | $124K | Sell |
17,656
-4,165
| -19% | -$29.3K | ﹤0.01% | 2745 |
|
|
2017
Q3 | $191K | Buy |
21,821
+95
| +0.4% | +$832 | ﹤0.01% | 2752 |
|
|
2017
Q2 | $198K | Buy |
+21,726
| New | +$198K | ﹤0.01% | 2763 |
|